Interferon regulatory factors in human lupus pathogenesis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Translational research : the journal of laboratory and clinical medicine

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.trsl.2011.01.006PMID 21575916PMCID PMC3096827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function

  2011cited by this paper
• The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies

  2011cited by this paper
• Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.

  2011cited by this paper
• A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients

  2011cited by this paper
• Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus

  2010cited by this paper
• Genetic regulation of serum cytokines in systemic lupus erythematosus.

  2010cited by this paper
• Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

  2010cited by this paper
• Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA‐ and/or RNA‐like analogues for treating lupus

  2010influential reference
• Promoter Variant of PIK3C3 Is Associated with Autoimmunity against Ro and Sm Epitopes in African-American Lupus Patients

  2010cited by this paper
• Important aspects of Toll-like receptors, ligands and their signaling pathways

  2010cited by this paper
• Interferon Alpha in Systemic Lupus Erythematosus

  2010cited by this paper
• Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.

  2010cited by this paper
• African-Derived Genetic Polymorphisms in TNFAIP3 Mediate Risk for Autoimmunity

  2010cited by this paper
• Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

  2009cited by this paper
• Association of IRF5 polymorphisms with activation of the interferon α pathway

  2009cited by this paper
• A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus

  2009influential reference
• Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers Increased Sensitivity to IFN-α in Lupus Patients In Vivo1

  2009cited by this paper
• IRF8 regulates myeloid and B lymphoid lineage diversification

  2009cited by this paper
• Age- and gender-specific modulation of serum osteopontin and interferon-α by osteopontin genotype in systemic lupus erythematosus

  2009cited by this paper
• Interferon Regulatory Factors in Hematopoietic Cell Differentiation and Immune Regulation

  2009cited by this paper
• Faculty Opinions recommendation of Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo.

  2009cited by this paper
• Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.

  2009cited by this paper
• IFN Regulatory Factor 5 Is Required for Disease Development in the FcγRIIB−/−Yaa and FcγRIIB−/− Mouse Models of Systemic Lupus Erythematosus

  2009cited by this paper
• Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans

  2008cited by this paper
• IRF4 addiction in multiple myeloma

  2008cited by this paper
• The IRF family transcription factors in immunity and oncogenesis.

  2008cited by this paper
• Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.

  2008cited by this paper
• Interferon alpha-induced lupus: proof of principle.

  2008cited by this paper
• Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci

  2008influential reference
• Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.

  2008cited by this paper
• Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese.

  2008cited by this paper
• The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus.

  2008cited by this paper
• Different Genetic Effects of Interferon Regulatory Factor 5 (IRF5) Polymorphisms on Systemic Lupus Erythematosus in a Korean Population

  2008cited by this paper
• Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms.

  2008cited by this paper
• Age- and sex-related patterns of serum interferon-alpha activity in lupus families.

  2008cited by this paper
• Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus

  2007influential reference
• High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.

  2007cited by this paper
• The IRF family, revisited.

  2007cited by this paper
• Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans

  2007cited by this paper
• Therapeutic role of beta-interferons in multiple sclerosis.

  2006cited by this paper
• A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

  2006influential reference
• Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus

  2006cited by this paper
• Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.

  2006cited by this paper
• Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C

  2005cited by this paper
• Interferons, interferon‐like cytokines, and their receptors

  2004cited by this paper
• Toll-Like Receptor 9 Signaling Activates NF-κB through IFN Regulatory Factor-8/IFN Consensus Sequence Binding Protein in Dendritic Cells1

  2004cited by this paper
• Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.

  2004cited by this paper
• Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

  2003cited by this paper
• Microarray Analysis of Interferon-regulated Genes in SLE

  2003cited by this paper
• Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.

  2003cited by this paper
• Review: Structure and Function of IRF-7

  2002cited by this paper
• Virus-specific Activation of a Novel Interferon Regulatory Factor, IRF-5, Results in the Induction of Distinct Interferon α Genes*

  2001cited by this paper
• Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour

  1990cited by this paper
• Immune interferon in the circulation of patients with autoimmune disease.

  1979cited by this paper

• Chronic inflammation in Long COVID relationship to autoimmune diseases.

  2025cites this paper
• Fibroblast IRF7-mediated chondrocyte apoptosis affects the progression of collapse in steroid-induced osteonecrosis of the femoral head

  2025cites this paper
• A novel clustered-based binary grey wolf optimizer to solve the feature selection problem for uncovering the genetic links between non-Hodgkin lymphomas and rheumatologic diseases

  2025cites this paper
• Roles of IRF4 in various immune cells in systemic lupus erythematosus.

  2024cites this paper
• Protein-protein interactions in cGAS-STING pathway: a medicinal chemistry perspective.

  2024cites this paper
• Comprehensive analysis of IRF8-related genes and immune characteristics in lupus nephritis

  2024cites this paper
• Type 2 hypersensitivity disorders, including systemic lupus erythematosus, Sjögren’s syndrome, Graves’ disease, myasthenia gravis, immune thrombocytopenia, autoimmune hemolytic anemia, dermatomyositis, and graft-versus-host disease, are THαβ-dominant autoimmune diseases

  2024cites this paper
• Type I IFN induces long-chain acyl-CoA synthetase 1 to generate a phosphatidic acid reservoir for lipotoxic saturated fatty acids

  2024cites this paper
• The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models

  2024cites this paper
• The Role of Genetic Risk Factors in Pathogenesis of Childhood-Onset Systemic Lupus Erythematosus

  2023influential citation
• Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis

  2023cites this paper
• Molecular mechanisms controlling age‐associated B cells in autoimmunity *

  2022cites this paper
• An integrative model of cardiometabolic traits identifies two types of metabolic syndrome

  2021cites this paper
• Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year

  2021cites this paper
• IMMUNOGENETICS OF LUPUS ERYTHEMATOSUS

  2020cites this paper
• Sjogren’s Syndrome

  2020cites this paper
• miR-106b-5p Inhibits IRF1/IFN-β Signaling to Promote M2 Macrophage Polarization of Glioblastoma

  2020cites this paper
• Lupus and Infections

  2019cites this paper
• Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects

  2019cites this paper
• Drug-Induced Lupus Erythematosus

  2019cites this paper
• Investigation of systemic lupus erythematosus (SLE) with integrating transcriptomics and genome wide association information.

  2019cites this paper
• IRF5 is increased in labouring myometrium and regulates pro-labour mediators.

  2018cites this paper
• Investigation of MicroRNA in Mitochondrial Apoptotic Pathway in Systemic Lupus Erythematosus

  2018cites this paper
• The IRF5 rs2004640 (G/T) polymorphism is not a genetic risk factor for systemic lupus erythematosus in population from south India

  2018cites this paper
• Vitamin D and juvenile systemic lupus erythematosus: Lights, shadows and still unresolved issues.

  2018cites this paper
• Novel Approach to the Treatment in Rheumatic Diseases: From Molecule to Value for Patient Novel Approach to the Treatment in Rheumatic Diseases: From Molecule to Value for Patient

  2018cites this paper
• Regulating STING in health and disease

  2017cites this paper
• Defining Biological Subsets in Systemic Lupus Erythematosus: Progress Toward Personalized Therapy

  2017cites this paper
• Chapter 10 – Systemic Lupus Erythematosus

  2017cites this paper
• Interferon regulatory factors: A key to tumour immunity

  2017cites this paper
• miRNA-451a Targets IFN Regulatory Factor 8 for the Progression of Systemic Lupus Erythematosus

  2017cites this paper
• Interferon regulatory factor signaling in autoimmune disease

  2017cites this paper
• ASSOCIATION OF UBE2L3 GENE POLYMORPHISM AND INTERLEUKIN 10 GENE POLYMORPHISM WITH SYSTEMIC LUPUS ERYTHEMATOSUS AMONG WOMEN POPULATION IN CHINA

  2017cites this paper
• Rubicon Modulates Antiviral Type I Interferon (IFN) Signaling by Targeting IFN Regulatory Factor 3 Dimerization

  2017cites this paper
• Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.

  2017cites this paper
• Cytokines: Diagnostic and Clinical Applications

  2016cites this paper
• A critical role for IRF5 in regulating allergic airway inflammation

  2016cites this paper
• Fas-Associated Factor 1 Negatively Regulates the Antiviral Immune Response by Inhibiting Translocation of Interferon Regulatory Factor 3 to the Nucleus

  2016cites this paper
• The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects.

  2016cites this paper
• Scavenging nucleic acid debris to combat autoimmunity and infectious disease

  2016cites this paper
• The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases

  2016cites this paper
• The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

  2016cites this paper
• Essential Requirement for IFN Regulatory Factor 7 in Autoantibody Production but Not Development of Nephritis in Murine Lupus

  2016cites this paper
• Transcriptional regulation of type I interferon responses of myeloid antigen presenting cells

  2016cites this paper
• Effects of IRF1 and IFN-β interaction on the M1 polarization of macrophages and its antitumor function

  2016cites this paper
• Association of vitamin D receptor gene polymorphism with the risk of systemic lupus erythematosus

  2015cites this paper
• Interferon regulatory factors: critical mediators of human lupus.

  2015cites this paper
• Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype

  2015cites this paper
• IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus

  2015cites this paper
• Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Clinical and Immunological Correlates

  2014cites this paper
• IRF 3 and interferon signature on pDC in SLE

  2014cites this paper
• Interferon Regulatory Factors and Autoimmune Diseases

  2014cites this paper
• Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations.

  2014cites this paper
• Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus

  2014cites this paper
• Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling.

  2014cites this paper
• Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population

  2014cites this paper
• Epigenetics and the IRFs: A complex interplay in the control of immunity and autoimmunity

  2014cites this paper
• Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjögren’s syndrome uncovered through gene expression meta-analysis

  2014cites this paper
• Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations

  2014cites this paper
• Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus

  2014cites this paper
• Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage.

  2014cites this paper
• Dysregulation of antiviral helicase pathways in systemic lupus erythematosus

  2014cites this paper
• C1q-Mediated Repression of Human Monocytes Is Regulated by Leukocyte-Associated Ig-Like Receptor 1 (LAIR-1)

  2014cites this paper
• Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice.

  2014cites this paper
• Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis

  2014cites this paper
• Skin Malar rash Discoid rash CNS Spleen Splenomegaly Kidney Serum Glomerulonephritis Anti-nuclear antibodies Blood IFN signature Plasma blasts Anemia Thrombocytopenia Neurological damage Affective disorder Lung Inflammation Joints Arthritis

  2014cites this paper
• IRF5-mediated signaling and implications for SLE.

  2014cites this paper
• [Physiopathology of systemic lupus erythematosus: a 2014 update].

  2014cites this paper
• IRF5, IRF8, and IRF7 in human pDCs — the good, the bad, and the insignificant?

  2013cites this paper
• Fueling autoimmunity: type I interferon in autoimmune diseases

  2013cites this paper
• Interferon regulatory factor 5 and autoimmune lupus

  2013cites this paper
• Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus

  2013cites this paper
• Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity.

  2013cites this paper
• IRF‐5 and NF‐κB p50 co‐regulate IFN‐β and IL‐6 expression in TLR9‐stimulated human plasmacytoid dendritic cells

  2013cites this paper
• Spontaneous activation of RNA-sensing pathways in autoimmune disease.

  2013cites this paper
• Familial Aggregation of High Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus

  2013cites this paper
• Genetic Variation near IRF8 is Associated with Serologic and Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis

  2013cites this paper
• The non-canonical IκB kinases IKKε and TBK1 as potential targets for the development of novel therapeutic drugs.

  2013cites this paper
• Interrelationship of dendritic cells, type 1 interferon system, regulatory T cells and toll-like receptors and their role in lichen planus and lupus erythematosus -- a literature review.

  2013cites this paper
• 2 - Physiopathologie du lupus érythémateux

  2013cites this paper
• An Overview of Cytokine Regulation of Inflammation and Immunity

  2013cites this paper
• Gene polymorphisms in SLE

  2013cites this paper
• Expressão imunoistoquímica dos receptores Toll-like 5 e 9 e do fator de transcrição Foxp3 em lesões orais de líquen plano e lúpus eritematoso

  2013cites this paper
• Genetic susceptibility to SLE: recent progress from GWAS.

  2013cites this paper
• Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus

  2012cites this paper
• Human myxovirus resistance protein 1 (MxA) as a useful marker in the differential diagnosis of subcutaneous lymphoma vs. lupus erythematosus profundus.

  2012cites this paper
• Estrogen and Signaling in the Cells of Immune System

  2012cites this paper
• The Autoimmune Disease Risk Allele of UBE2L3 in African American Patients with Systemic Lupus Erythematosus: A Recessive Effect Upon Subphenotypes

  2012cites this paper
• Activation and regulation of interferon-β in immune responses

  2012cites this paper
• Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus

  2012cites this paper
• Relationship Between Angiotensin-converting Enzyme Insertion/Deletion Gene Polymorphism and Systemic Lupus Erythematosus/Lupus Nephritis: A Systematic Review and Metaanalysis

  2012cites this paper
• Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways

  2012cites this paper
• The genetics of lupus: a functional perspective

  2012cites this paper
• Drug-Induced Lupus: Etiology, Pathogenesis, and Clinical Aspects. Etiology, Pathogenesis, and Clinical Aspects.

  2012cites this paper
• Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.

  2012cites this paper
• Regulation of T helper cell differentiation by interferon regulatory factor family members

  2012cites this paper
• IFN Signature That Precedes Disease Onset Sle1/Sle2/Sle3 Lupus-Prone Mice Express an Myeloid Dendritic Cells from B6.NZM

  2012cites this paper
• Myeloid Dendritic Cells from B6.NZM Sle1/Sle2/Sle3 Lupus-Prone Mice Express an IFN Signature That Precedes Disease Onset

  2012cites this paper
• Pregnancy-associated inflammatory markers are elevated in pregnant women with systemic lupus erythematosus.

  2012cites this paper
• Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha.

  2012cites this paper